Obiettivo
Diabetic retinopathy (DR), the leading cause of blindness among working-age individuals in developed countries has been classically considered to be a microcirculatory disease of the retina. However, there is growing evidence to suggest that retinal neurodegeneration is an early event in the pathogenesis of DR. For this reason, it is reasonable to hypothesize that therapeutic strategies based on neuroprotection will be effective not only in preventing or arresting retinal neurodegeneration but also in preventing the development and progression of the early stages of DR (ie. microaneurysms and/or retinal thickness).
EUROCONDOR (European Consortium for the Early Treatment of Diabetic Retinopathy) is a solid and well balanced consortium (ophthalmologists, endocrinologists, basic researchers) which has been created in order to implement the first clinical trial using eye drops for treatment of the early stages of DR. The participants are top leaders in their field and central readings will be performed by the Coordinating Centre of the European Vision Institute Clinical Research Network (EVICR.Net).
The main objectives of the project are the following:
Primary objective: To assess whether the selected neuroprotective drugs (brimonidine and somatostatin) administered topically are able to prevent or arrest neurodegeneration, as well as the development and progression of the early stages of DR.
Secondary objectives: 1) To determine the prevalence of functional abnormalities related to neurodegeneration in those patients without or with minimal microvascular damage under ophthalmoscopic examination. 2) To compare the effectiveness of the selected drugs. 3) To evaluate the local and systemic adverse effects of the selected drugs. 4) To identify those patients most prone to progressive worsening (characterization of phenotypes and circulating biomarkers). 5) To determine the molecular mechanisms by which the selected drugs exert their beneficial effects.
Campo scientifico
Argomento(i)
Invito a presentare proposte
FP7-HEALTH-2011-two-stage
Vedi altri progetti per questo bando
Meccanismo di finanziamento
CP-FP - Small or medium-scale focused research projectCoordinatore
08035 Barcelona
Spagna
Mostra sulla mappa
Partecipanti (17)
3000 548 Coimbra
Mostra sulla mappa
5230 Odense M
Mostra sulla mappa
89081 Ulm
Mostra sulla mappa
20132 Milano
Mostra sulla mappa
35122 Padova
Mostra sulla mappa
GL53 7AN CHELTENHAM
Mostra sulla mappa
08007 Barcelona
Mostra sulla mappa
EC1V 2PD London
Mostra sulla mappa
75012 Paris
Mostra sulla mappa
L69 7ZX Liverpool
Mostra sulla mappa
B4 7ET Birmingham
Mostra sulla mappa
10124 Torino
Mostra sulla mappa
46012 Valencia
Mostra sulla mappa
28006 Madrid
Mostra sulla mappa
1090 Bruxelles / Brussel
Mostra sulla mappa
08777 SANTA QUINTI DE MEDIONA
Mostra sulla mappa
Partecipazione conclusa
28029 MADRID
Mostra sulla mappa